Kymera raises $150M PIPE with 2.77M shares at $26 and 3M pre-funded warrants

Kymera Therapeutics, Inc.

Private placement of 2,769,228 common shares at $26.00 and 3,000,000 pre-funded warrants at $25.9999.
Gross proceeds of ~$150M expected; closing on August 22, 2022 subject to customary conditions.
Proceeds to fund working capital, R&D, and general corporate purposes.
Post-closing cash, equivalents, and investments expected to exceed $600M as of August 31, 2022.
Offering led by a US healthcare fund and BVF; includes Avoro, EcoR1, Redmile, Rock Springs, T. Rowe Price.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.